FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2906092085> ?p ?o ?g. }

• W2906092085 abstract "Endoscopic surgical treatment represents the gold standard in patients with lower urinary tract symptoms (LUTS) when medical treatment fails. In the past years there has been a growing interest in intraprostatic injections which represent a minimally invasive alternative for those patients not suitable for surgery. Aim of our study is to systematically review all the available data on intraprostatic injections for the treatment of LUTS patients with benign prostatic enlargement (BPE).A systematic review of the literature using the Medline, Scopus and Web of Science databases for relevant articles published until June 2018 was performed using both the Medical Subjects Heading and free test protocols. The MeSH search was conducted by combining the following terms: Intraprostatic Injections, Botulinum Toxin A, Onabotulinum, Ethanol, Lower Urinary tract Symptoms, Benign prostatic enlargement, Benign Prostatic Hyperplasia, NX1207, PRX302. Each article's title and abstract were reviewed for their appropriateness and their relevance with regards to the relationship to intraprostatic injections.Intraprostatic injections for the treatment of LUTS/BPE patients may be performed using different products as: ethanol, onabotulinum toxin A, NX1207 and PRX 302. Ethanol, the first agent for intraprostatic use, showed promising results in prospective trials, however, the rare but serious adverse events associated with extraprostatic diffusion of ethanol stopped its use. Many studies on onabotulinum toxin A (BotoxR) have been performed, however, two large randomized clinical trials showed no differences in terms of symptoms improvements and flow improvements when compared to placebo. Two new promising drugs NX 1207 and PRX 302 have been developped in the past years. NX 1207 showed lack of efficacy in the two large European phase III RCT. PRX 302 showed promising results in phase I and II studies, however, definitive results from a large phase III randomized controlled trial (RCT) are awaited before drawing any definitive conclusions.Intraprostatic injections are still to be considered investigational for the minimally invasive management of LUTS/BPE patients. Emerging data suggest a possible role of new agents in the near future when definitive data of ongoing RCTs will be available." @default.
• W2906092085 created "2019-01-01" @default.
• W2906092085 creator A5014135786 @default.
• W2906092085 creator A5061191487 @default.
• W2906092085 creator A5083952077 @default.
• W2906092085 creator A5087569213 @default.
• W2906092085 date "2018-12-01" @default.
• W2906092085 modified "2023-10-18" @default.
• W2906092085 title "Intraprostatic injections for lower urinary tract symptoms/benign prostatic enlargement treatment" @default.
• W2906092085 cites W1720025183 @default.
• W2906092085 cites W1761187655 @default.
• W2906092085 cites W1924925786 @default.
• W2906092085 cites W1970781058 @default.
• W2906092085 cites W1971539190 @default.
• W2906092085 cites W1982920003 @default.
• W2906092085 cites W1989217788 @default.
• W2906092085 cites W2008454771 @default.
• W2906092085 cites W2008869107 @default.
• W2906092085 cites W2021506773 @default.
• W2906092085 cites W2021530168 @default.
• W2906092085 cites W2022708922 @default.
• W2906092085 cites W2027744939 @default.
• W2906092085 cites W2030470179 @default.
• W2906092085 cites W2036787880 @default.
• W2906092085 cites W2037473701 @default.
• W2906092085 cites W2044586938 @default.
• W2906092085 cites W2064475804 @default.
• W2906092085 cites W2066452721 @default.
• W2906092085 cites W2067393850 @default.
• W2906092085 cites W2068504032 @default.
• W2906092085 cites W2093963005 @default.
• W2906092085 cites W2095919356 @default.
• W2906092085 cites W2098369027 @default.
• W2906092085 cites W2102194067 @default.
• W2906092085 cites W2153060268 @default.
• W2906092085 cites W2162720064 @default.
• W2906092085 cites W2166903012 @default.
• W2906092085 cites W2320719223 @default.
• W2906092085 cites W2737405214 @default.
• W2906092085 cites W2978734959 @default.
• W2906092085 cites W2023349692 @default.
• W2906092085 doi "https://doi.org/10.23736/s0393-2249.18.03233-2" @default.
• W2906092085 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30298711" @default.
• W2906092085 hasPublicationYear "2018" @default.
• W2906092085 type Work @default.
• W2906092085 sameAs 2906092085 @default.
• W2906092085 citedByCount "10" @default.
• W2906092085 countsByYear W29060920852019 @default.
• W2906092085 countsByYear W29060920852020 @default.
• W2906092085 countsByYear W29060920852021 @default.
• W2906092085 countsByYear W29060920852022 @default.
• W2906092085 crossrefType "journal-article" @default.
• W2906092085 hasAuthorship W2906092085A5014135786 @default.
• W2906092085 hasAuthorship W2906092085A5061191487 @default.
• W2906092085 hasAuthorship W2906092085A5083952077 @default.
• W2906092085 hasAuthorship W2906092085A5087569213 @default.
• W2906092085 hasConcept C121608353 @default.
• W2906092085 hasConcept C126322002 @default.
• W2906092085 hasConcept C126894567 @default.
• W2906092085 hasConcept C142724271 @default.
• W2906092085 hasConcept C168563851 @default.
• W2906092085 hasConcept C197934379 @default.
• W2906092085 hasConcept C204787440 @default.
• W2906092085 hasConcept C27081682 @default.
• W2906092085 hasConcept C2776235491 @default.
• W2906092085 hasConcept C2776478404 @default.
• W2906092085 hasConcept C2777562237 @default.
• W2906092085 hasConcept C2779478474 @default.
• W2906092085 hasConcept C535046627 @default.
• W2906092085 hasConcept C71924100 @default.
• W2906092085 hasConceptScore W2906092085C121608353 @default.
• W2906092085 hasConceptScore W2906092085C126322002 @default.
• W2906092085 hasConceptScore W2906092085C126894567 @default.
• W2906092085 hasConceptScore W2906092085C142724271 @default.
• W2906092085 hasConceptScore W2906092085C168563851 @default.
• W2906092085 hasConceptScore W2906092085C197934379 @default.
• W2906092085 hasConceptScore W2906092085C204787440 @default.
• W2906092085 hasConceptScore W2906092085C27081682 @default.
• W2906092085 hasConceptScore W2906092085C2776235491 @default.
• W2906092085 hasConceptScore W2906092085C2776478404 @default.
• W2906092085 hasConceptScore W2906092085C2777562237 @default.
• W2906092085 hasConceptScore W2906092085C2779478474 @default.
• W2906092085 hasConceptScore W2906092085C535046627 @default.
• W2906092085 hasConceptScore W2906092085C71924100 @default.
• W2906092085 hasLocation W29060920851 @default.
• W2906092085 hasLocation W29060920852 @default.
• W2906092085 hasOpenAccess W2906092085 @default.
• W2906092085 hasPrimaryLocation W29060920851 @default.
• W2906092085 hasRelatedWork W1989217788 @default.
• W2906092085 hasRelatedWork W2005938254 @default.
• W2906092085 hasRelatedWork W2021270740 @default.
• W2906092085 hasRelatedWork W2040027434 @default.
• W2906092085 hasRelatedWork W2085830368 @default.
• W2906092085 hasRelatedWork W2095919356 @default.
• W2906092085 hasRelatedWork W2096351556 @default.
• W2906092085 hasRelatedWork W2139520708 @default.
• W2906092085 hasRelatedWork W2744942272 @default.
• W2906092085 hasRelatedWork W3209906421 @default.
• W2906092085 isParatext "false" @default.
• W2906092085 isRetracted "false" @default.

• next